Literature DB >> 35960377

Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo.

Iakovos Amygdalos1, Enno Hachgenei2, Luisa Burkl2, David Vargas3, Paul Goßmann4, Laura I Wolff4, Mariia Druzenko4, Maik Frye2, Niels König2, Robert H Schmitt2,5, Alexandros Chrysos4, Katharina Jöchle4, Tom F Ulmer4, Andreas Lambertz4, Ruth Knüchel-Clarke3, Ulf P Neumann4, Sven A Lang4.   

Abstract

PURPOSE: Optical coherence tomography (OCT) is an imaging technology based on low-coherence interferometry, which provides non-invasive, high-resolution cross-sectional images of biological tissues. A potential clinical application is the intraoperative examination of resection margins, as a real-time adjunct to histological examination. In this ex vivo study, we investigated the ability of OCT to differentiate colorectal liver metastases (CRLM) from healthy liver parenchyma, when combined with convolutional neural networks (CNN).
METHODS: Between June and August 2020, consecutive adult patients undergoing elective liver resections for CRLM were included in this study. Fresh resection specimens were scanned ex vivo, before fixation in formalin, using a table-top OCT device at 1310 nm wavelength. Scanned areas were marked and histologically examined. A pre-trained CNN (Xception) was used to match OCT scans to their corresponding histological diagnoses. To validate the results, a stratified k-fold cross-validation (CV) was carried out.
RESULTS: A total of 26 scans (containing approx. 26,500 images in total) were obtained from 15 patients. Of these, 13 were of normal liver parenchyma and 13 of CRLM. The CNN distinguished CRLM from healthy liver parenchyma with an F1-score of 0.93 (0.03), and a sensitivity and specificity of 0.94 (0.04) and 0.93 (0.04), respectively.
CONCLUSION: Optical coherence tomography combined with CNN can distinguish between healthy liver and CRLM with great accuracy ex vivo. Further studies are needed to improve upon these results and develop in vivo diagnostic technologies, such as intraoperative scanning of resection margins.
© 2022. The Author(s).

Entities:  

Keywords:  Colorectal liver metastases; Deep learning; Hepatobiliary; Machine learning; Neural networks; Optical coherence tomography

Year:  2022        PMID: 35960377     DOI: 10.1007/s00432-022-04263-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  4 in total

1.  Rapid and high-resolution imaging of human liver specimens by full-field optical coherence tomography.

Authors:  Yue Zhu; Wanrong Gao; Yuan Zhou; Yingcheng Guo; Feng Guo; Yong He
Journal:  J Biomed Opt       Date:  2015-11       Impact factor: 3.170

2.  Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.

Authors:  Manish Motwani; Damini Dey; Daniel S Berman; Guido Germano; Stephan Achenbach; Mouaz H Al-Mallah; Daniele Andreini; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin Delago; Millie Gomez; Heidi Gransar; Martin Hadamitzky; Joerg Hausleiter; Niree Hindoyan; Gudrun Feuchtner; Philipp A Kaufmann; Yong-Jin Kim; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Hugo Marques; Gianluca Pontone; Gilbert Raff; Ronen Rubinshtein; Leslee J Shaw; Julia Stehli; Todd C Villines; Allison Dunning; James K Min; Piotr J Slomka
Journal:  Eur Heart J       Date:  2017-02-14       Impact factor: 29.983

3.  Diagnosing colorectal abnormalities using scattering coefficient maps acquired from optical coherence tomography.

Authors:  Yifeng Zeng; William C Chapman; Yixiao Lin; Shuying Li; Matthew Mutch; Quing Zhu
Journal:  J Biophotonics       Date:  2020-10-22       Impact factor: 3.207

4.  MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction.

Authors:  Lea Hitpass; Iakovos Amygdalos; Paul Sieben; Vanessa Raaff; Sven Lang; Philipp Bruners; Christiane K Kuhl; Alexandra Barabasch
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.